VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | Understanding the impact of therapies on treatment-emergent mutations in MF to prevent progression

Jeanne Palmer, MD, Mayo Clinic, Phoenix, AZ, talks on the importance of understanding the mechanism of action of new disease-modifying therapies in myelofibrosis (MF) to prevent treatment-related clonal evolution and disease progression. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter